Biocon has witnessed encouraging results in the use of its novel
biologic Itolizumab for treating some Covid-19 related conditions, the
pharmaceutical company said on Friday. Biocon said the first set of
trials using the drug were done in Mumbai and Delhi.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/itolizumab-use-for-coronavirus-encouraging-says-biocon/articleshow/75766590.cms
No comments:
Post a Comment